Literature DB >> 10192196

Significant differences in the interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease.

A Nemetz1, A Köpe, T Molnár, A Kovács, J Fehér, Z Tulassay, F Nagy, M A García-González, A S Peña.   

Abstract

BACKGROUND: There is growing evidence of the importance of genetic predisposition and the activation of the mucosal immune system in the pathogenesis of inflammatory bowel disease. Thus, genes involved in the regulation of inflammation are receiving increased attention. We have studied whether Crohn's disease (CD) or ulcerative colitis (UC) is associated with certain allelic combinations of IL1B/IL1RA gene polymorphisms in a different European population than the ones studied so far.
METHODS: Ninety-six patients with UC, 97 with CD, and 132 healthy individuals (HC) were typed for the polymorphic regions in exon 5 of the IL1B gene and in intron 2 of the IL1RA gene, using polymerase chain reaction-based methods.
RESULTS: In CD homozygotes for allele 1 in IL1B gene polymorphism were more often present (72% versus 28%; P = 0.01) in the subgroup of patients carrying at least one copy of allele 2 in IL1RA gene polymorphism. This association was not found in HC (HC versus CD; P = 0.03) or UC. However, in UC patients with pancolitis a similar trend was observed (75% versus 25%). Several genotype combinations characterized by the presence of allele 2 of the IL1RA gene polymorphism were more common in CD (P = 0.001) and UC (P = 0.049) than in HC.
CONCLUSIONS: Our data support the concept that CD and severe UC have a genetic disequilibrium in the distribution of IL1B and IL1RA gene polymorphisms. These findings together with functional studies will contribute to the understanding of the pathogenesis of the chronicity of inflammation in these diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192196     DOI: 10.1080/00365529950173041

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1 beta exon 5, and IL-1 receptor antagonist: nonassociation with endometriosis.

Authors:  Y Y Hsieh; C C Chang; F J Tsai; J Y Wu; Y R Shi; H D Tsai; C H Tsai
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

Review 2.  Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Authors:  Peter Laszlo Lakatos; Simon Fischer; Laszlo Lakatos; Istvan Gal; Janos Papp
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

3.  The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer.

Authors:  M A Garcia-Gonzalez; A Lanas; S Santolaria; J B Crusius; M T Serrano; A S Peña
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

4.  Significance of IL-1RA Polymorphism in Iranian Patients with Inflammatory Bowel Disease.

Authors:  Nasser Ebrahimi Daryani; Maryam Sadr; Shirin Moossavi; Sepideh Shahkarami; Samaneh Soltani; Elham Farhadi; Nima Rezaei
Journal:  Dig Dis Sci       Date:  2014-12-03       Impact factor: 3.199

5.  Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.

Authors:  A Nemetz; M Tóth; M A García-González; T Zágoni; J Fehér; A S Peña; Z Tulassay
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

6.  Polymorphisms of the IL-1beta and IL-1beta-inducible genes in ulcerative colitis.

Authors:  Hiroaki Nohara; Yuki Saito; Singo Higaki; Naoko Okayama; Yuichiro Hamanaka; Kiwamu Okita; Yuji Hinoda
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

7.  Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.

Authors:  Collins Ouma; Gregory C Davenport; Gordon A Awandare; Christopher C Keller; Tom Were; Michael F Otieno; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

8.  Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist.

Authors:  Andrew W Stadnyk; Moorix M W Yeung; Sen Rong Yan
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

9.  Genetic polymorphisms of interleukin-1 beta and osteosarcoma risk.

Authors:  Yu He; XinJun Liang; ChunQing Meng; ZengWu Shao; Yong Gao; Qiang Wu; JianXiang Liu; Hong Wang; ShuHua Yang
Journal:  Int Orthop       Date:  2014-05-31       Impact factor: 3.075

10.  Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients.

Authors:  Priyatharsan Yoganathan; Jean-Benoit Rossel; Sebastian Bruno Ulrich Jordi; Yannick Franc; Luc Biedermann; Benjamin Misselwitz; Martin Hausmann; Gerhard Rogler; Michael Scharl; Isabelle Frey-Wagner
Journal:  BMC Gastroenterol       Date:  2021-08-03       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.